4//SEC Filing
Kapadia Sandip 4
Accession 0001415889-25-009357
CIK 0001802665other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:10 PM ET
Size
8.9 KB
Accession
0001415889-25-009357
Insider Transaction Report
Form 4
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-29−15,000→ 15,000 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2025-03-29+15,000→ 15,000 total - Tax Payment
Common Stock
2025-03-29$33.19/sh−8,014$265,985→ 6,986 total
Footnotes (2)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001677141
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:10 PM ET
- Size
- 8.9 KB